Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

When damage to the liver caused by alcohol or viral infections persists, liver fibrosis progresses and replaces tissue with ...

Chronic hepatitis C is a growing health problem worldwide that has attracted increased attention in recent years. Treatment with peginterferon and ribavirin combination had previously been the ...

The KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease notes that direct-acting antivirals effectively treat ...

HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens ...

Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ...

New medications called direct-acting antivirals (DAAs) have transformed the treatment of hepatitis C. Twelve weeks on one of these drugs cures the infection in 95 percent or more of people who take it ...

Chronic hepatitis C infection has been linked to a higher risk of pancreatic cancer. Learn more about findings from a major ...

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

The best way to prevent hepatitis B infection is vaccination. The vaccines are highly effective at preventing infection in ...

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that ...